Tech Company Financing Transactions
TheraVida Funding Round
On 6/30/2012, TheraVida raised $1 million in funding from Sanderling Ventures and private investors.
Transaction Overview
Company Name
Announced On
6/30/2012
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Investors
Sanderling Ventures (Roger Flugel)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4819 Emperor Blvd. 400
Durham, NC 27517
USA
Durham, NC 27517
USA
Phone
Website
Email Address
Overview
Using a unique and patent-protected combination drug technology, TheraVida is able to develop urology pharmaceutical products that have significantly better side effect and safety profiles, when compared with predecessor therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin McGraw
Browse more venture capital transactions:
Prev: 6/29/2012: Context Relevant venture capital transaction
Next: 6/30/2012: Ceregene venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs